Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Amyris, Inc.    AMRS

AMYRIS, INC.

(AMRS)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/23/2020 09/24/2020 09/25/2020 09/28/2020 09/29/2020 Date
2.53(c) 2.64(c) 2.71(c) 2.77(c) 2.84 Last
3 146 031 1 530 824 1 241 699 1 396 154 148 714 Volume
-8.50% +4.35% +2.65% +2.21% +2.53% Change
More quotes
Financials (USD)
Sales 2020 184 M - -
Net income 2020 -259 M - -
Net Debt 2020 - - -
P/E ratio 2020 -2,25x
Yield 2020 -
Sales 2021 287 M - -
Net income 2021 -91,6 M - -
Net Debt 2021 - - -
P/E ratio 2021 -8,66x
Yield 2021 -
Capitalization 567 M 567 M -
Capi. / Sales 2020 3,09x
Capi. / Sales 2021 1,97x
Nbr of Employees 561
Free-Float 56,7%
More Financials
Company
Amyris, Inc. is an industrial biotechnology company. The Company is primarily focused on applying its technology platform to engineer, manufacture and sell high performance, natural, sustainably-sourced products into the Health & Wellness, Clean Beauty, and Flavor and Fragrance markets. Its technology platform enables users to rapidly engineer microbes and use them as catalysts to metabolize renewable, plant-sourced... 
More about the company
Notations Surperformance© of Amyris, Inc.
Trading Rating : - Investor Rating :
More Ratings
All news about AMYRIS, INC.
09/22AMYRIS : Pipette Clean Baby Brand Selected By Alibaba for Accelerated Entry into..
AQ
09/21AMYRIS' : Pipette Clean Baby Brand Selected By Alibaba For Accelerated Entry Int..
PR
09/16AMYRIS : Continues Market Adoption of Its Sweetener with Approval by Health Cana..
AQ
09/15AMYRIS : to Provide Business Overview and Update on Current Affairs at H.C. Wain..
AQ
09/15AMYRIS : Continues Market Adoption Of Its Sweetener With Approval By Health Cana..
PU
09/15AMYRIS : Continues Market Adoption Of Its Sweetener With Approval By Health Cana..
PR
09/14AMYRIS : Responds To LAVVAN's Filing of Lawsuit On September 10, 2020
AQ
09/14AMYRIS : to Provide Business Overview And Update On Current Affairs At H.C. Wain..
PR
09/11AMYRIS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form..
AQ
09/11AMYRIS : Responds To LAVVAN's Filing Of Lawsuit On September 10, 2020
PR
09/10AMYRIS : LAVVAN, Inc. Files $881 Million Federal Lawsuit Against Amyris, Inc. Fo..
AQ
09/10LAVVAN, INC. : Files $881 Million Federal Lawsuit Against Amyris, Inc. For Paten..
PR
09/09AMYRIS : to Present at H.C. Wainwright 22nd Annual Global Investment Conference ..
AQ
09/08AMYRIS : to Present at H.C. Wainwright 22nd Annual Global Investment Conference ..
PR
09/01AMYRIS : Scales First Fermentation-Based Cannabinoid
PR
More news
News in other languages on AMYRIS, INC.

- No features available -

More news
Chart AMYRIS, INC.
Duration : Period :
Amyris, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AMYRIS, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 10,00 $
Last Close Price 2,77 $
Spread / Highest target 297%
Spread / Average Target 261%
Spread / Lowest Target 225%
EPS Revisions
Managers
NameTitle
John G. Melo President, Chief Executive Officer & Director
Geoffrey Mark Duyk Chairman
Eduardo Alvarez Chief Operating Officer
Hermanus Kieftenbeld Chief Financial Officer
Sunil Chandran Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
AMYRIS, INC.-10.36%567
AIR LIQUIDE8.72%75 414
SAUDI BASIC INDUSTRIES CORPORATION-5.32%71 109
WANHUA CHEMICAL GROUP CO., LTD.25.19%32 415
LYONDELLBASELL INDUSTRIES N.V.-24.63%23 773
HENGLI PETROCHEMICAL CO.,LTD.16.04%19 284